“Tradamixina TP” Compound in Monotherapy for Three Months in Patients with LUTS: Observational Study on Improvement of Urinary Symptoms and Sexual Function in Men — Oak Academic Publishing
Research ArticleOpen AccessGoogle Scholar indexed
“Tradamixina TP” Compound in Monotherapy for Three Months in Patients with LUTS: Observational Study on Improvement of Urinary Symptoms and Sexual Function in Men
Department of Urology—University Federico II of Naples, Via S. Pansini, Naples, Italy
,
Department of Urology—University Federico II of Naples, Via S. Pansini, Naples, Italy
,
AORN Cardarelli Napoli, Italy
,
Department of Urology—University Federico II of Naples, Via S. Pansini, Naples, Italy
1 Department of Urology—University Federico II of Naples, Via S. Pansini, Naples, Italy
2 Department of Urology—University Federico II of Naples, Via S. Pansini, Naples, Italy
3 AORN Cardarelli Napoli, Italy
4 Department of Urology—University Federico II of Naples, Via S. Pansini, Naples, Italy
Introduction: Benign Prostatic Hypertrophy (BPH) and Lower Urinary Tract Symptoms (LUTS) frequently affect the male population after the age of 50. Moreover, it is well known that there is a correlation of these symptoms with Erectile Dysfunction (ED) that can reach a frequency of roughly 52% in men aged between 40 and 70 years old. In this study, we aimed at evaluating the effect of a new natural compound “Tradamixina TP” (composed of 80 mg of the algae Ecklonia Bicyclis, 100 mg of Tribulus terrestris and 100 mg of Chitosan Water-soluble oligosaccharide 320 mg of Serenoa repens) in the improvement of Lower Urinary Tract Symptoms (LUTS). Materials & Methods: One-hundred patients with an average age of 64 years old and who were not taking any medication or phytotherapy for prostatic hypertrophy or erectile dysfunction were recruited in the study. All participants were subjected to serum prostate antigen (PSA) and uroflowmetry measuring maximal urine flow/sec (Qmax), at baseline and after 12 weeks. In addition, patients were asked to take the Tradamixina TP for 3 months and to complete at the beginning and end of the treatment the following questionnaires: 1) the IPSS investigating the level of LUTS, and 2) the IIEF-15 investigating the erectile dysfunction. Results: After the treatment, the IPSS scores were lower than those before the treatment. Moreover, a significant effect was found for the IIEF erectile subdomain with scores that were significantly higher at 12 weeks than at baseline. A similar result was found for the IIEF overall subdomain. A decrease of total serum PSA was also observed. Conclusions: After 3 months of daily treatment, the new compound “Tradamixina TP” improved patients’ sexual function, LUTS and led also to a decrease in serum PSA levels.
Rosen, R., Altwein, J., Boyle, P., et al. (2003) Lower Urinary Tract Symptoms and Male Sexual Dysfunction: The Multinational Survey of the Aging Male (MSAM-7). European Urology, 44, 637-649. https://doi.org/10.1016/j.eururo.2003.08.015
Berry, S.J., Coeffy, D.S., Walsh, P.C., et al. (1984) The Development of Human Benign Prostatic Hyperplasia with Age. Journal of Urology, 132, 474-479. https://doi.org/10.1016/S0022-5347(17)49698-4
Irwin, D.E., Milsom, I., Hunskaar, S., et al. (2006) Population-Based Survey of Urinary Incontinence, Overactive Bladder, and Other Lower Urinary Tract Symptoms in Five Countries: Results of the EPIC Study. European Urology, 50, 1306-1315. https://doi.org/10.1016/j.eururo.2006.09.019
Abrams, P., Cardozo, L., Fall, M., et al. (2003) The Standardisation of Terminology in Lower Urinary Tract Function: Report from the Standardisation Sub-Committee of the International Continence Society. Urology, 61, 37-49. https://doi.org/10.1016/S0090-4295(02)02243-4
Bruschini, H., Schmidt, R.A. and Tanagho, E.A. (1978) Neurologic Control of Prostatic Secretion in the Dog. Investigative Urology, 15, 288-290.
Isaacs, J.T. (1994) Etiology of Benign Prostatic Hyperplasia. European Urology, 25, 6-9. https://doi.org/10.1159/000475324
Smith, E.R. and Lebeaux, M.I. (1970) The Mediation of the Canine Prostatic Secretion Provoked by Hypogastric Nerve Stimulation. Investigative Urology, 7, 313-318.
Burnett, A.L., Maguire, M.P., Chamness, S.L., Ricker, D.D., Takeda, M., Lepor, H. and Chang, T.S. (1995) Characterization and Localization of Nitric Oxide Synthase in the Human Prostate. Urology, 45, 435-439. https://doi.org/10.1016/S0090-4295(99)80012-0
Higgins, J.R. and Gosling, J.A. (1989) Studies on the Structure and Intrinsic Innervation of the Normal Human Prostate. The Prostate. Supplement, 2, 5-16. https://doi.org/10.1002/pros.2990150503
Tsujii, T., Azuma, H., Yamaguchi, T. and Oshima, H. (1992) A Possible Role of Decreased Relaxation Mediated by Beta-Adrenoceptors in Bladder Outlet Obstruction by Benign Prostatic Hyperplasia. British Journal of Pharmacology, 107, 803-807. https://doi.org/10.1111/j.1476-5381.1992.tb14527.x
Caine, M., Raz, S. and Zeigler, M. (1975) Adrenergic and Cholinergic Receptors in the Human Prostate, Prostatic Capsule and Bladder Neck. British Journal of Urology, 47, 193-202. https://doi.org/10.1111/j.1464-410X.1975.tb03947.x
Jungblut, T., Aumuller, G., Malek, B. and Melchior, H. (1989) Age Dependency and Regional Distribution of Enkephalinergic Nerves in Human Prostate. Urologia Internationalis, 44, 352-356. https://doi.org/10.1159/000281539
Lange, W. and Unger, J. (1990) Peptidergic Innervation within the Prostate Gland and Seminal Vesicle. Urological Research, 18, 337-340. https://doi.org/10.1007/BF00300783
Lepor, H. and Shapiro, E. (1984) Characterization of Alpha1 Adrenergic Receptors in Human Benign Prostatic Hyperplasia. Journal of Urology, 132, 1226-1229. https://doi.org/10.1016/S0022-5347(17)50110-X
Di Silverio, F., D’Eramo, G., Lubrano, C., Flammia, G.P., Sciarra, A., Palma, E., et al. (1992) Evidence That Serenoa repens Extract Displays an Antiestrogenic Activity in Prostatic Tissue of Benign Prostatichypertrophy Patients. European Urology, 2, 309-314. https://doi.org/10.1159/000474863
Briganti, A., Capitanio, U., Suardi, N., et al. (2009) Benign Prostatic Hyperplasia and Its Aetiologies. European Urology Supplements, 8, 865-871. https://doi.org/10.1016/j.eursup.2009.11.002
Gacci, M., Eardley, I. and Giuliano, F. (2011) Critical Analysis of the Relationship between Sexual Dysfunctions and Lower Urinary Tract Symptoms Due to Benign Prostatic Hyperplasia. European Urology, 60, 809-825. https://doi.org/10.1016/j.eururo.2011.06.037
Iacono, F., Stanojevic, N., Skrodzka, M., et al. (2015) Improving Male Sexual Function with a Nutraceutical Composite Containing Tribulus terrestris, Alga Eisenia bicyclis and Chitosan Oligosaccharide Water Soluble: A Multicentric, Randomized, Placebo-Controlled Study. The Journal of Sexual Medicine, 12, 294-381. https://doi.org/10.1111/jsm.12956
Jung, W.-K., Heo, S.-J., Jeon, Y.-J., et al. (2009) Inhibitory Effects and Molecular Mechanism of Dieckol Isolated from Marine Brown Alga on Cox-2 and iNOS in Microglial Cells. Journal of Agricultural and Food Chemistry, 57, 4439-4446. https://doi.org/10.1021/jf9003913
Do, J., Choi, S., Choi, J. and Hyun, J.S. (2013) Effects and Mechanism of Action of a Tribuusterrestris Extract on Penile Erection. Korean Journal of Urology, 54, 183-188. https://doi.org/10.4111/kju.2013.54.3.183
Russo, A., Maisto, E., Romis, L., et al. (2016) Use of a Natural Compound Made of Eisenia bicyclis Seaweed, Tribulus terrestris and Water-Soluble Chitosan Oligosaccharide, in Male Sexual Asthenia with Mild or Mild-Moderate Erectile Dysfunction and Serum Testosterone Levels at the Lower Limit of Normal. Health, 8, 1668-1678. https://doi.org/10.4236/health.2016.815162
Santos, C.A., Reis, L.O., Destro-Saade, R., Luiza-Reis, A. and Fregonesi, A. (2014) Tribulus terrestris versus Placebo in the Treatment of Erectile Dysfunction: A Prospective, Randomized, Double Blind Study. Actas Urologicas Espanolas, 38, 244-248. https://doi.org/10.1016/j.acuroe.2014.03.009
Roaiah, M.F., El Khayat, Y.I., Gamal El Din, S.F. and Abd El Salam, M.A. (2016) Pilot Study on the Effect of Botanical Medicine (Tribulus terrestris) on Serum Testosterone Level and Erectile Function in Aging Males with Partial Androgen Deficiency (PADAM). Journal of Sex and Marital Therapy, 7, 297-301. https://doi.org/10.1080/0092623X.2015.1033579
Neychev, V. and Mitev, V. (2016) Pro-Sexual and Androgen Enhancing Effects of Tribulus terrestris L.: Fact or Fiction. Journal of Ethnopharmacology, 179, 345-355. https://doi.org/10.1016/j.jep.2015.12.055
Chapple, C.R., Crowe, R., Gilpin, S.A., Gosling, J. and Burnstock, G. (1991) The Innervation of the Human Prostate Gland—The Changes Associated with Benign Enlargement. Journal of Urology, 146, 1637-1644. https://doi.org/10.1016/S0022-5347(17)38203-4
Nickel, J.C., Downey, J., Young, I. and Boang, S. (1999) Asymptomatic Inflammation and/or Infection in Benign Prostatic Hyperplasia. BJU International, 84, 976-981.
Elkahwaji, J.E. and Zhong, W. (2007) Hopkins Chronic Bacterial Infection and Inflammation Incite Reactive Hyperplasia in a Mouse Model of Chronic Prostatitis. Prostate, 67, 14. https://doi.org/10.1002/pros.20445
Leslie, C.C. (1997) Properties and Regulation of Cytosolic Phospholipase A2. The Journal of Biological Chemistry, 272, 16709-16712. https://doi.org/10.1074/jbc.272.27.16709
Mariotto, S., Suzuki, Y., Persichini, T., Colasanti, M., Suzuki, H. and Cantoni, O. (2007) Cross-Talk between No and Arachidonic Acid in Inflammation. Current Medicinal Chemistry, 14, 1940-1944. https://doi.org/10.2174/092986707781368531
Tacklind, J., et al. (2012) Serenoa repens for Benign Prostatic Hyperplasia. Cochrane Database of Systematic Reviews, 12, Cd001423. https://doi.org/10.1002/14651858.CD001423.pub3
Ryu, Y.W., et al. (2015) Comparison of Tamsulosin plus Serenoa repens with Tamsulosin in the Treatment of Benign Prostatic Hyperplasia in Korean Men: 1-Year Randomized Open Label Study. Urologia Internationalis, 94, 187. https://doi.org/10.1159/000366521